News Conference News NY Valves 2025 Solid, Early Surgical Results With Polymer Mitral Valve Todd Neale July 02, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News STS 2025 Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’ Yael L. Maxwell February 05, 2025
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TVT 2023 Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes Michael O'Riordan June 13, 2023
News Conference News ACC 2023 UK Mini Mitral: No Clear Win for Minimally Invasive MV Repair Todd Neale March 13, 2023
News Conference News ACC 2023 Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients Todd Neale March 05, 2023
News Conference News STS 2023 Surgeons ‘Implore’ Colleagues to Learn TEER Lest They Become ‘Dinosaurs’ Yael L. Maxwell February 02, 2023
News Conference News EuroPCR 2022 Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN Caitlin E. Cox May 27, 2022
News Conference News ACC 2022 Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years Michael O'Riordan April 04, 2022
News Conference News TCT 2021 SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years Todd Neale November 05, 2021